From the publishers of JADPRO

MPN Resource Center


Outcome of 129 pregnancies in polycythemia vera patients: A report of the European LeukemiaNET

Last Updated: Thursday, June 29, 2023

As part of the European LeukemiaNET MPN Pregnancy Project, researchers retrospectively analyzed 129 polycythemia vera (PV) pregnancies and found that live birth rate among patients with PV could be significantly improved by the antenatal introduction of PV-specific therapy. Among the pregnancies that received PV-specific therapy 78.2% resulted in live births, compared with 47.6% among pregnancies without PV-specific therapy. Administration of acetylsalicylic acid (ASA) in combination with low-molecular weight heparin (LMWH; P = 0.001) or interferon (alone or in combination with ASA and/or LMWH; P = 0.023) was associated with a statistically significant lower risk of miscarriage than standard antenatal care.  


News & Literature Highlights

British Journal of Haematology

‘MPN Genomic Calculator’: real‐life use in a young population with essential thrombocythaemia


Significant association of cutaneous adverse events with hydroxyurea: results from a prospective non-interventional study in BCR-ABL1-negative myeloproliferative neoplasms (MPN) - on behalf of the German Study Group-MPN

Thrombosis Research

Patient outcomes in myeloproliferative neoplasm-related thrombosis: Insights from the National Inpatient Sample

British Journal of Haemtology

Real‐world non‐interventional long‐term post‐authorisation safety study of ruxolitinib in myelofibrosis

Cancer Medicine

Depressive symptoms and myeloproliferative neoplasms: Understanding the confounding factor in a complex condition

Expert Review of Hematology

Developing strategies to reduce the duration of therapy for patients with myeloproliferative neoplasms

European Society for Medical Oncology (ESMO) Congress 2021 Abstract

Final results of a phase II study of tipifarnib in chronic myelomonocytic leukemia (CMML) and other myelodysplastic/myeloproliferative neoplasms (MDS/MPN)

European Society for Medical Oncology (ESMO) Congress 2021 Abstract

Treatment outcomes and antibody immunity to SARS-CoV-2 in patients with hematological malignancies

Annals of Hematology

Evaluation of the need for cytoreduction and its potential carcinogenicity in children and young adults with myeloproliferative neoplasms

Clinical Lymphoma Myeloma and Leukemia

Mortality and causes of death of patients with polycythemia vera: analysis of the REVEAL prospective, observational study